| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $145.9M | +40.5% |
| Cost of Revenue | $70.6M | +58.4% |
| Gross Profit | $75.3M | +27.0% |
| R&D Expense | $20.6M | -12.1% |
| SG&A Expense | $54.9M | -3.1% |
| Operating Income | -$48.5M | +41.1% |
| Pre-tax Income | -$33.1M | +38.8% |
| Income Tax | $62K | — |
| Net Income | -$33.1M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $49.1M | +32.8% |
| Accounts Receivable | $30.8M | +8.6% |
| Inventory | $9.3M | -45.1% |
| Current Assets | $151.3M | +24.6% |
| Total Assets | $304.4M | +13.6% |
| Current Liabilities | $123.0M | +27.2% |
| Long-term Debt | $28.6M | — |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $18.7M | +160.5% |
| Investing Cash Flow | -$41.8M | -2889.7% |
| Financing Cash Flow | $35.4M | +1856.9% |
| +38.7% |
| EPS (Basic) | -$0.20 | +41.2% |
| EPS (Diluted) | -$0.20 | +41.2% |
| Total Liabilities |
| $185.0M |
| +23.0% |
| Stockholders' Equity | $119.4M | +1.5% |